Skip to main content
Signal8

Herskowitz Neil

SEC insider (Form 3/4/5 filer). CIK 0001298246. Director at Journey Medical Corp (DERM) and 3 other issuers. 10 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in SCOTTSDALE, AZ.

Companies Herskowitz Neil has filed insider reports for

  • Journey Medical Corp (DERM): Director
  • MUSTANG BIO, INC. (MBIO): Director
  • Checkpoint Therapeutics, Inc. (CKPT): Director
  • AVENUE THERAPEUTICS, INC. (ATXI): Director
Herskowitz Neil profile photo

Herskowitz Neil

CIK: 0001298246

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (20.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (70.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (10.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

Journey Medical Corp logo
DERM

Journey Medical Corp

Director
MUSTANG BIO, INC. logo
MBIO

MUSTANG BIO, INC.

Director
Checkpoint Therapeutics, Inc. logo
CKPT

Checkpoint Therapeutics, Inc.

Director
AVENUE THERAPEUTICS, INC. logo
ATXI

AVENUE THERAPEUTICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (10 total)

  • Journey Medical Corp logo
    DERM

    Journey Medical Corp

    Jul 1, 2026
    Award
    Direct
    50K shares-
  • Journey Medical Corp logo
    DERM

    Journey Medical Corp

    Jun 25, 2026
    Award
    Direct
    10K shares-
  • MUSTANG BIO, INC. logo
    MBIO

    MUSTANG BIO, INC.

    Dec 30, 2025
    Sale
    Direct
    247 shares at avg. $0.96$237.614
  • Journey Medical Corp logo
    DERM

    Journey Medical Corp

    Aug 5, 2025
    Award
    Direct
    20K shares-
  • Journey Medical Corp logo
    DERM

    Journey Medical Corp

    Jun 25, 2025
    Award
    Direct
    7.2K shares-
  • Checkpoint Therapeutics, Inc. logo
    CKPT

    Checkpoint Therapeutics, Inc.

    May 30, 2025
    Tender Offer
    Direct
    147K shares-
  • Checkpoint Therapeutics, Inc. logo
    CKPT

    Checkpoint Therapeutics, Inc.

    May 28, 2025
    Award
    Direct
    12.2K shares-
  • Checkpoint Therapeutics, Inc. logo
    CKPT

    Checkpoint Therapeutics, Inc.

    Dec 13, 2024
    Award
    Direct
    17.6K shares-
  • AVENUE THERAPEUTICS, INC. logo
    ATXI

    AVENUE THERAPEUTICS, INC.

    Dec 2, 2024
    Sale
    Direct
    23 shares at avg. $2.00$46
  • AVENUE THERAPEUTICS, INC. logo
    ATXI

    AVENUE THERAPEUTICS, INC.

    Sep 23, 2024
    Award

    Employee stock option (right to buy)

    Direct
    30K shares-

1-10 of 10